February 27, 2020 / 12:53 PM / a month ago

BRIEF-BioLine RX Announces Notice Of Allowance From USPTO For Patent Covering Motixafortide In Combination With Anti-PD-1 For The Treatment Of Any Type Of Cancer

Feb 27 (Reuters) - BioLine RX Ltd:

* BIOLINERX ANNOUNCES NOTICE OF ALLOWANCE FROM USPTO FOR PATENT COVERING MOTIXAFORTIDE (BL-8040) IN COMBINATION WITH ANTI-PD-1 FOR THE TREATMENT OF ANY TYPE OF CANCER

* BIOLINE RX LTD - PROGRESSION-FREE AND OVERALL SURVIVAL DATA FROM TRIPLE COMBINATION ARM EXPECTED IN MID-2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below